BBVA
PACB icon

Banco Bilbao Vizcaya Argentaria’s Pacific Biosciences PACB Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,417
Closed -$1.05M – 801
2021
Q1 		$1.05M Buy
+23,417
New +$820K 0.02% 481

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's PACB Position: Q2 2021 in Review

Banco Bilbao Vizcaya Argentaria sold out of Pacific Biosciences (PACB) in Q2 2021, closing a stake of 23,417 shares — an estimated $1.05M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in PACB in Q1 2021 and held it in 1 quarter. The position peaked at $1.05M in Q1 2021. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Pacific Biosciences position as of Q2 2021 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 23,417 Pacific Biosciences shares in Q2 2021, an estimated $1.05M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Pacific Biosciences in Q1 2021 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Pacific Biosciences position peaked at $1.05M in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2021, filed 6 Aug 2021.